| 000 | 01275 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250514214048.0 | ||
| 264 | 0 | _c20050224 | |
| 008 | 200502s 0 0 eng d | ||
| 022 | _a0003-4967 | ||
| 024 | 7 |
_a10.1136/ard.2003.017780 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVis, M | |
| 245 | 0 | 0 |
_aBone mineral density in patients with rheumatoid arthritis treated with infliximab. _h[electronic resource] |
| 260 |
_bAnnals of the rheumatic diseases _cFeb 2005 |
||
| 300 |
_a336-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xpharmacology |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aVoskuyl, A E | |
| 700 | 1 | _aWolbink, G J | |
| 700 | 1 | _aDijkmans, B A C | |
| 700 | 1 | _aLems, W F | |
| 773 | 0 |
_tAnnals of the rheumatic diseases _gvol. 64 _gno. 2 _gp. 336-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/ard.2003.017780 _zAvailable from publisher's website |
| 999 |
_c15326899 _d15326899 |
||